Position in AGEN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$88,654
-$11,138 QoQ
Shares Held
28,972
-3.0% QoQ
Ownership
0.064%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#36
of 103 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in AGEN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CAPTRUST FINANCIAL ADVISORS holds $169,003,876 across 125 Biotechnology names. AGEN ranks #91 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
36,464 | $22,736,762 | |
| 2 | RPRX |
Royalty Pharma plc
|
337,298 | $18,912,298 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
35,471 | $17,619,509 | |
| 4 | EXEL |
Exelixis, Inc.
|
303,042 | $16,488,515 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
34,607 | $10,938,926 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
125,946 | $9,857,793 | |
| 7 | CELC |
Celcuity Inc.
|
71,445 | $7,474,575 | |
| 8 | INCY |
Incyte Corp
|
50,301 | $5,702,121 |
All Filings in AGEN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $88,654 | 28,972 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $99,792 | 29,878 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $94,473 | 30,087 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $118,133 | 30,684 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $168,619 | 36,897 | Shares | Sole | 2025-08-15 | |
| 2024-06-30 | $181,687 | 10,847 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $129,290 | 222,915 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $157,030 | 189,193 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $621,061 | 549,612 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $1,089,388 | 680,868 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $1,015,470 | 668,072 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,521,511 | 633,963 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $1,258,067 | 613,692 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $1,190,561 | 613,692 | Shares | Sole | 2022-08-23 | |
| 2022-03-31 | $1,347,700 | 547,846 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,747,467 | 542,692 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,840,208 | 540,992 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $2,929,573 | 533,620 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,447,018 | 531,992 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,628,133 | 511,992 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,985,646 | 496,412 | Shares | Sole | 2020-11-17 | |
| 2020-06-30 | $1,872,298 | 476,412 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,167,210 | 476,412 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||